New Mexico employs about 4,000 people in the biotechnology/healthcare industry.
They are employed by over 100 companies and institutions including Los Alamos National Laboratory, Santa Fe Institute, Lovelace Respiratory Research Institute and the National Center for Genome Research, as well as the University of New Mexico’s Center for Biomedical Engineering. Around $5.0 billion in research and development funds are drawn to these and other facilities every year for pure research and market-driven development. These institutions have technology transfer offices which allow private companies access to their output. They also have extensive research facilities which can be made available to innovative companies, thereby reducing the cost of development and shortening the time to market.
Biotechnology/Healthcare in New Mexico is unique because it comes from a melding of several disciplines, including informatics, physics, nuclear medicine, molecular biology, genomics and defense-related research. This mix has created multifaceted research and commercial opportunities, and has fostered the development of a community focused around Bio-Informatics, or Bio-Diagnostics. Current projects around the state include: nuclear medicine, bio-sensors, genetic research, microfluidics for digestible diagnostics, and spectroscopic solutions for infection or blood level detection.
The industry is strongly linked to the activities of local research institutions, as substantial Federal investment dominates the activity landscape. A number of innovative companies have developed their own intellectual property and cultivated niche markets in areas outside of acknowledged institutional competencies.
Posted by Administrator at 12:26 PM